Caption Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Caption Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-86,859	Closed	-$1.21M	–	1842
2022 Q3	$1.21M	Buy	+86,859	New	+$1.4M	0.02%	799
2022 Q2	–	Sell	-30,000	Closed	-$488K	–	1955
2022 Q1	$488K	Buy	+30,000	New	+$470K	0.01%	1145
2021 Q1	–	Sell	-11,971	Closed	-$296K	–	1473
2020 Q4	$296K	Sell	11,971 -6,029	-33%	-$200K	0.01%	802
2020 Q3	$747K	Buy	18,000 +17,000	+1,700%	+$781K	0.02%	696
2020 Q2	$48K	Sell	1,000 -17,200	-95%	-$1.33M	﹤0.01%	872
2020 Q1	$1.15M	Sell	18,200 -16,300	-47%	-$1.46M	0.06%	373
2019 Q4	$4.28M	Buy	+34,500	New	+$3.09M	0.14%	195

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Caption Management's ICPT Position: Q4 2022 in Review

Caption Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2022, closing a stake of 86,859 shares — an estimated $1.21M sold.

Caption Management first reported a position in ICPT in Q4 2019 and held it in 7 quarters. The position peaked at $4.28M in Q4 2019. 144 funds tracked by Wall St. Rank hold ICPT as of Q4 2022.

Caption Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Caption Management sold 86,859 Intercept Pharmaceuticals, Inc. shares in Q4 2022, an estimated $1.21M.
Caption Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2019 and held it in 7 quarters.
Caption Management's Intercept Pharmaceuticals, Inc. position peaked at $4.28M in Q4 2019.
144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.